Long-Acting Injectable Buprenorphine Updates

Updates on Long-Acting Injectable Buprenorphine for People with Opioid Use Disorder

This webinar is part of NAHEWD's national series Bridging HIV and SUD: Innovations in the Field. The series is highlighting various innovative models and approaches to treating substance use disorder (SUD) in people at risk for and living with HIV. This session will review current guidelines and evidence for long-acting injectable (LAI) buprenorphine in people with opioid use disorder (OUD), as well as emerging evidence and best practices around direct-to-inject buprenorphine initiation. 

Register & learn more